Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
CervoMed Inc. (NASDAQ: CRVO)
CRVO Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-8.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
CRVO Stock Analysis
CRVO
PE Ratio:
CRVO
PEG Ratio:
Not Available
CRVO
Forward EPS Growth (12 month):
0.00%
CRVO
PS Ratio:
13.2
CRVO
PSG Ratio:
Not Available
CRVO
Forward Revenue Growth (12 month):
0.00%
CRVO Articles
No data was found